Two Palliative Care Giants Dr Jennifer Vidrine ST4 Palliative Medicine.

Slides:



Advertisements
Similar presentations
Nausea & Vomiting ‘made easy’.
Advertisements

Nausea and vomiting.
September 5 th – 8 th 2013 Nottingham Conference Centre, United Kingdom
LIFE-LIMITING ILLNESS
Prof. Hanan Hagar Pharmacology Department College of Medicine
Palliative Care Dr Rachel Dawson. Objectives Increase your confidence in dealing with palliative care cases.
ACUTE CANCER PAIN Dr Mike Bennett Senior Clinical Lecturer in Palliative Medicine St Gemma’s Hospice and University of Leeds.
Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship.
Analgesic Trade Secrets
Bowel Symptoms 1: Nausea & Vomiting Dr Iain Lawrie.
Nausea and Vomiting James Hallenbeck, MD Director, Palliative Care Services, Palo Alto VAHCS, Stanford University.
Department of Pharmacology
Palliative Care – update for the acute physician Dr Anne Goggin.
NHMRC Nausea Studies.
Management of Nausea & Vomiting
CANCER PAIN MANAGEMENT. Pain control should encompass “total pain” Pain management specialists should not work in isolation Education is fundamental to.
You can control pain Module 9. Learning objectives ■ Describe the 3 steps of the analgesic ladder ■ Give examples of drugs from each step of the ladder.
SYRINGE DRIVERS Coranne Rice.
{ Management of Advanced Breathlessness Dr Phil Wilkins, Norfolk and Norwich University Hospital and Priscilla Bacon Lodge, Norwich.
Pain Assessment and Management
Mosby items and derived items © 2005, 2002 by Mosby, Inc. CHAPTER 51 Antiemetic and Antinausea Agents.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 52 Antiemetic and Antinausea Drugs.
(Drugs Used for Nausea and vomiting) Antiemetic drugs Prof. Alhaider Nausea and vomiting may be manifestations of many conditions. However, a useful abbreviation.
Becky Owen 22/2/12. Overview Case Study Clinical Presentation Management Case Study Update Summary Questions.
P ALLIATIVE C ARE By Hannah Wright GPST1 Teaching 17 th April 2013.
Antiemetics and Emetics
Evaluation and Treatment of Nausea and Vomiting
Anxiety and Depression in Paediatric Palliative Care Dr Emma Heckford July 17 th 2012 Disclaimer: Whilst every effort has been made to ensure that the.
Post Liverpool Care Pathway End of Life Conference Wednesday 14 May 2014 Dr Catherine J Dent Associate Specialist Macmillan Specialist Palliative Care.
Managing Symptoms in Palliative Care. Aims  To gain an awareness of the most common symptoms in patients with life limiting diseases and why these occur.
Palliative Care in Elderly Dr Asso Faraidoon Ali Amin MRCP(UK),DGM.
Pain Cases GPVTS Nov 08. Case 1 : Hospice patient - RM 67/f 2004: Ovarian cancer oophrectomy +salpingectomy chemotherapy 2008: Pathological fracture to.
PATIENT CASE Module 4 Date of preparation: June 2015 HQ/EFF/15/0024h.
Dignity and Symptom Control Rachel Sheils GSFCH Conference
By Dr Marie Joseph MB BS FRCP Medical Director & Consultant in Palliative Medicine St Raphael’s Hospice, Surrey and Macmillan Consultant, Epsom & St Helier.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 53 Antiemetic and Antinausea Drugs.
Adjuvants or Co-analgesics Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Palliative Care In Heart Failure Dr Chi-Chi Cheung Consultant in Palliative Medicine 19 th March 2015.
Side effects and toxicity of analgesics Disclaimer: This presentation contains information on the general principles of pain management. This presentation.
Pain II: Cancer Pain Management Dr. Leah Steinberg.
Dublin November 13 th 2011 By Dr. Edward O’Sullivan 13-Nov
Chapter 25 Emetics and Antiemetics. Emetics p585 Agents that induce vomiting – Used in overdoses Example – Ipecac syrup Inappropriate use of emetics –
Let’s Talk About Pain Karen Cox-Seignoret M.B.,B.S., M.R.C.G.P.
Case study Which antidepressant Dr. Matthew Miller.
Dr Barbara Downes June Introduction Patient group An over view of managing pain Revision of the basics Case examples Drugs and conversions in the.
Nausea & Vomiting Dr. Lucy Harris SpR Palliative Medicine September 2014.
Safe Opioid Prescribing MedicinesDoseFrequencyRouteQuantity Morphine Sulphate MR 10mg tablets10mgBD OralSupply 28 tablets (Twenty eight tablets) Morphine.
Pain control and controlled drug prescribing Gayle Munro Specialist Pharmacist
Foundation Teaching Wendy Caddye Senior CNS Acute Pain.
Find out more online: Opioids and anti-emetics in palliative care Dr Claire Curtis Consultant in Palliative Medicine.
Pain Ladder and Opiate Conversion Christopher Haigh Medicines Optimisation Pharmacist Bolton CCG.
Top Tips in Palliative Care Dr Claire Curtis (in collaboration with the Worcestershire Specialist Palliative Care Teams) Nov 2012 Click to continue.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
Management Of Nausea And Vomiting In Palliative Care
What is Palliative Care? n Support and comfort for individuals and families living with chronic or life- threatening illnesses n Focuses on: –Relieving.
GP Clinical Governance Meeting 13 th of July 2011 Dr Marion Lieth Consultant in Palliative Medicine, Bolton Hospital and Bolton Hospice Common issues:
Step 5 workshop. Step 5 - Plan Recognising when an individual enters the dying phase Appropriate and inappropriate hospital admissions at end of life.
Chapter 33 Therapy of Gastrointestinal Disorders: Peptic Ulcers, GERD, and Vomiting.
Pain and Symptom Management
Palliative Care in the Outpatient Setting: Pain Management
Anjanette Acosta Physiology 3
PALLIATIVE MEDICINE NAUSEA, VOMITING, BOWEL OBSTRUCTION
THE MODERN MANAGEMENT OF PAIN IN PALLIATIVE MEDICINE
Other Gastrointestinal Drugs
Nausea & Vomiting ‘made easy’.
OPIOID TOXICITY AND SPINAL ANALGESIA
How do I manage pain and agitation?
Nausea & Vomiting in Cancer Patients
Nausea and vomiting in Cancer Patients
Cholinesterase Inhibitors: Actions and Uses
Presentation transcript:

Two Palliative Care Giants Dr Jennifer Vidrine ST4 Palliative Medicine

Overview A broad overview of palliative care in relation to general practice Pain Case 1 BREAK Nausea and Vomiting Case 2 Round Up

Palliative Care Recognised as distinct entity since 1980s First modern hospice opened 1967 Based on concept of ‘Holistic’ care Palliative care teams Not just for patients with cancer

GPs and palliative care

“GPs found looking after palliative care patients satisfactory and varied but burdensome” Found barriers on three levels: – Personal – Relational – Organisational

Challenges faced… Personal – Knowledge symptom and symptom control – Technical procedures in pts who want to stay at home (ie Catheter) – Small numbers of palliative care patients in a year – Emotional – Time constraints – Lack of psychological support in an autonomous worker

Relational – Communication Between pts, carers, other HCPs – ‘Territory’ (GP? SPCT? Hospital team?)

Organisational – Bureaucracy – Obtaining medications (Controlled drugs, CSCI etc) – Need to organise care/social work review etc

They conclude Barriers exist It is imperative to support GPs as the frontline of service provision Role of specialist palliative care teams in this (both specialist knowledge and emotional support)

Common Symptoms Pain Nausea and Vomiting Shortness of Breath Anxiety/Psychological Distress

Common Symptoms Pain Nausea and Vomiting Shortness of Breath Anxiety/Psychological Distress

Pain

Nociceptive vs neuropathic pain

Neuropathic pain Disproportionate to stimulation of the nociceptor Leads to: – Hyperalgesia (exaggerated and prolonged pain response to a mildly painful stimulus) – Allodynia (Pain produced by a stimulus that is not normally painful, such as light touch) – Spontaneous pain No protective function Pathological pain

Distinguishing the two… History History History Thinking abut possible/likely aetiologies What has the pain responded to thus far?

Very often in palliative care it is a combination of both Requires combination treatments (Often one won’t cut it) Often requires some lateral thinking

WHO analgesic ladder

Correct the Correctable Anticancer treatment (DXT, Chemo) Treat precip factors (cough, constipation, retention) Non-Drug Positioning Modification to way of life, environment Relaxation therapies Surgery (eg bone pinning) Drug Relieve background pain Prescribe rescue Nerve Blockade Spinal Analgesia

An approach… Patient specific Tend to start with low dose strong opiate (eg Oramorph 2.5-5mg PRN) If possible also give regular paracetamol Ask patient/relative to write down the following: DateTimeSite PainPain score /10 before What taken Pain Score /10 after Notes/Si de effects

Review in a couple of days. Establish if opioid making ANY difference Establish any side effects Calculate what has been taken in last 24 hours (ie 4 doses of 5mg=20mg) Start BD preparation of long acting opiate Explain need to continue with Breakthroughs and ongoing monitoring. Breakthrough is 1/6 total daily opioid dose (except Alfentanil which is 1/10 th )

Established on Morphine but still in pain? Would an adjunct help? Steroids (Dexamethasone) TCA (Amitriptyline) Anti-epileptics (Gabapentin/Pregabalin) Very often end up on combination

Evidence Base Amitriptiline-OD dosing, syrup available. Gabapentin- syrup available, TDS Pregabablin- ?more tolerable, BD, only tablets Valporate- OD, syrup available, RCT conflicting Clonazepam- Concurrent anxiolytic and muscle relaxant properties, SC Anti-epilepticNNT Carbmazepine3.3 Gabapentin3.5 Lamotrigine4 Sodium valporate 2-2.5?

Other things to consider NSAIDs – If no contra-indications – Esp if inflamm element of pain – Useful in bone pain – Ibuprofen used most frequently – Ketorolac useful as can be used subcut (Generally only for short spells/at end of life) Bisphosphonates

Particular Challenges Episodic Pain High anxiety element (Total pain) Non-concordance Consider referral/involvement SPCT

What might be offered… Methadone Ketamine Spinal Lines (epidural/intrathecal line) Nerve Blocks Cordotomy (Division of lateral spinothalamic tracts in the spine) Involvement of clinical psychology

Case 1 Break up into groups of 3-5 Look at the case and start to think about the issues involved for 20 mins Try to approach as holistically as possible Feed back to group.

Comfort Break

Nausea & Vomiting

Nausea & Vomiting-Background Extremely common in cancer patients Deeply distressing Vomiting generally tolerated better than nausea “Last night we went to a Chinese dinner at six and a French dinner at nine, and I can feel the shark’s fins navigating unhappily in the Burgundy” Peter Flemming, Letter from Yunnanfu, March 1938

Reality of the situation Often as/more challenging to treat than pain Many patients have multifactorial N&V Absorption of the very stuff we are giving them to make them better May well require more than one anti-emetic Systematic/logical approach….

Questions to ask Nausea/vomiting predominant? Timing? What is vomited? (Consistency, volume, colour) Feel better after vomiting? Associated features? Exacerbating/relieving factors Are there are any probable causes? (eg Constipation)

Identify specifically treated causes Constipation-Laxatives/PR intervention (Prevention) Gastritis-Would PPI help? Oropharyngeal Candida-Often difficult to treat Hypercalcaemia-IV hydration +/- Bisphosphonate Pain-Optimise analgesia If drug induced how essential is drug? Treat infection

Think about non-drug measures Select anti-emetic based on most likely cause Basic principals: – Give regular antiemetics – Need to carefully assess risk of non-absorption and consider alt routes (CSCI) early – If you are relatively sure about cause consider maximising dose rather than switching (esp Metoclopramide)

Two ‘broad’ avenues.. 1.Gastric-stasis 2.Chemically mediated (central)

1. Gastric Stasis-presentation Early Satiety Large volume vomits Undigested food Relief after vomiting Hiccoughs/belching Exacerbated by eating/medcations

1.Gastric stasis-causes Slowed gastric emptying ‘Squashed stomach’ due to Hepatomegally Ascites Subacute obstruction (consider specialist input)

1.Gastric Stasis-management Prokinetic eg Metoclopramide Targets peripheral (and central) Dopamine (D2) receptors. Caution in young females CAUTION IN PARKINSON’S DISEASE/SYNDROMES Dose: 10-20mg tds/qds – CSCI mg/24 hours Domperidone (less side effects but limited routes) OBSERVE FOR INTESTINAL COLIC

Vomiting Centre Chemical Medication Biochemical Toxins GI tract Obstruction Gastric stasis Irritation/ hepatic Vestibular Motion sickness Local tumour Medication Central Anxiety Pain Cerebral mets Raised ICP Dopamine Seretonin 3 Dopamine Seretonin 4 Acetylcholine Histamine CTZ Metoclopramide

Two ‘broad’ avenues.. 1.Gastric-stasis 2.Chemically mediated (central)

2.Central Causes-presentation Constant nausea No/little relief after vomiting May be able to identify cause Other signs drug toxicity

Central-Causes Drugs: Opiates Antidepressants AEDs Electrolyte Imbalance Renal Failure Hypercalcaemia Sepsis Anxiety Pain Raised Intracranial Pressure Ischemic Bowel

2. Central Causes-Management Cyclizine Antihistaminic/Anticholinergic antiemetic acting at ACh M and H 1 receptors Acts centrally to help with vagally mediated nausea. Can give anticholinergic side effects Dose: 25-50mg tds – CSCI: 150mg/24 hour Particularly useful if raised intracerebral pressure

Vomiting Centre Chemical Medication Biochemical Toxins GI tract Obstruction Gastric stasis Irritation/ hepatic Vestibular Motion sickness Local tumour Medication Central Anxiety Pain Cerebral mets Raised ICP Dopamine Seretonin 3 Dopamine Seretonin 4 Acetylcholine Histamine CTZ Cyclizine

2. Central Causes-Management Haloperidol Useful for chemical induced nausea (inc Drug induced) Centrally acting anti-emetic acting at D 2 receptor at the CTZ Contraindications Dose: 1.5mg Nocte ( mg bd) – CSCI: 2.5-5mg/24 hours

Vomiting Centre Chemical Medication Biochemical Toxins GI tract Obstruction Gastric stasis Irritation/ hepatic Vestibular Motion sickness Local tumour Medication Central Anxiety Pain Cerebral mets Raised ICP Dopamine Seretonin 3 Dopamine Seretonin 4 Acetylcholine Histamine CTZ Haloperidol

If at first you don’t succeed Remember often multifactorial Consider increasing dose Consider combinations (that target diff receptors) Dex 4mg will often enhance affect anti-emetic (unknown mech) Levomepromazine

Vomiting Centre Chemical Medication Biochemical Toxins GI tract Obstruction Gastric stasis Irritation/ hepatic Vestibular Motion sickness Local tumour Medication Central Anxiety Pain Cerebral mets Raised ICP Dopamine Seretonin 3 Dopamine Seretonin 4 Acetylcholine Histamine CTZ Levomepromazine

Chemotherapy Induced N&V Ondansetron often used Best to time limit it’s use Headaches Constipation Has a very specific role Consider anticipatory n&v – Levomepromazine – Lorazapam

Case 2 Break up into groups of 3-5 Look at the case and start to think about the issues involved for 20 mins Try to approach as holistically as possible Feed back to group.

In summary A whistle stop tour of two pretty meaty subjects The importance of a thorough assessment in managing symptoms The importance of a systematic approach in managing them Make use of community SPCT/hospice advice lines if in doubt.

Any questions?

Watson, M. Lucas, C. Hoy, A. Wells, J (2010) The Oxford Handbook of palliative care. Oxford university press. Twycross, R. Wilcock, A. Palliative care formulary 4 th Edition (2012) Palliativedrugs.com Groot, M. Vernooij-Dassen, M. Crul, B. Grol, R. (2005) General practitioners (GPs) and palliative care: percieved tasks and barriers in daily practice. J Pall Med. (19)